In the CRC microenvironment, the loss of Claudin-7 in epithelial barriers triggers NF-κB/CXCL1 activation, which reprograms neutrophils and impairs CD8+ T-cell function, further reducing the effectiveness of immunotherapy [99]. Here, CD8A is linked to colorectal carcinoma.